Therapeutic failure in a renal transplant patient with Pneumocystis jiroveci pneumonia: a case report.

OBJECTIVES

Pneumocystis jiroveci pneumonia is common in immunocompromised individuals.

PATIENTS

This case report describes an immunosuppressed patient who acquired P jiroveci pneumonia 6 months after renal transplant surgery.

RESULTS

The patient experienced many pneumonia-related complications and adverse effects from drug therapy, and despite treatment with various antibiotic agents, he died on the 62nd day after his admission to the intensive care unit.

CONCLUSIONS

The therapeutic failure of the drug of choice (co-trimoxazole) was evident. This case raises questions about the development of P jiroveci resistance to current therapies.